From start to finish: Five lessons for making mRNA jabs for TB
The need for a new tuberculosis vaccine is as urgent as ever, and now a local pharmaceutical company is joining the race to find one
Afrigen Biologics
You are viewing the M&G archive site.
Go to mg.co.za →
The Mail & Guardian has a new home.
Visit the new mg.co.za →